317 results on '"Wordsworth S"'
Search Results
52. Management of patients with suspected infectious diarrhoea in hospitals in England
53. MANAGING THE LONG-TERM CARE OF INFLAMMATORY BOWEL DISEASE PATIENTS: THE COST TO EUROPEAN HEALTH CARE PROVIDERS
54. A Re-run of Siemens, Wintershall and Hochtief on Most-Favoured-Nation Clauses: Daimler Financial Services AG v Argentine Republic
55. Microarray technology in healthcare: A cost analysis in idiopathic learning disability
56. Adaptation of the By-Band randomized clinical trial to By-Band-Sleeve to include a new intervention and maintain relevance of the study to practice.
57. Cost of fertility treatment and live birth outcome in women of different ages and BMI
58. PRM221 - Health Economics Analysis Plans: Where Are We Now?
59. Regional differences in the frequency of the c. 985A >G ACADM mutation: findings from a meta‐regression of genotyping and screening studies
60. Abaclat and Others v Argentine Republic: Jurisdiction, Admissibility and Pre-conditions to Arbitration
61. Early referral and planned initiation of dialysis: what impact on quality of life?
62. Elevated urinary catecholamines and adrenal haemorrhage mimicking phaeochromocytoma
63. Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost-effective?
64. PTU-029 Managing the long-term care of inflammatory bowel disease patients: the cost to European health care providers
65. DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
66. Rare presentation of Trisomy 8 syndrome
67. Bladder repair through vaginal incision and simultaneous replacement of tension-free vaginal tape
68. Molecular testing for somatic mutations in common cancers: the views of UK oncologists
69. Molecular testing for somatic cancer mutations: a survey of current and future testing in UK laboratories
70. Conservative laparoscopic approach with systemic medical management of an ovarian ectopic gestation
71. Pseudocyesis in a teenager using long-term contraception
72. Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials
73. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions
74. Early referral and planned initiation of dialysis: what impact on quality of life?
75. Ultrasound scanning by general practitioners: is it worthwhile?
76. The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease
77. Regional differences in the frequency of the c. 985A>G ACADM mutation: findings from a meta-regression of genotyping and screening studies.
78. The effects of shifts in the balance of care on general practice workload
79. A framework for priority setting
80. PRM33 - Identification Of Items For A Standardised Resource-Use Measure: Review Of Current Instruments
81. Exemestane in adjuvant treatment of early breast cancer in postmenopausal women: results of a UK cost-effectiveness model
82. A framework for priority setting [12]
83. Preferences for general practice jobs: A survey of principals and sessional GPs
84. What is the value of collecting detailed costing data in clinical trials?
85. PRM33 Identification Of Items For A Standardised Resource-Use Measure: Review Of Current Instruments
86. Development and assessment of a genetic and environmental risk model for colorectal cancer
87. The use of biomedical big data for economic analyses of genome sequencing in rare genetic diseases: a case study from the 100,000 Genomes Project
88. Methods for assessing the costs of transfusion management strategies in cardiac surgery
89. Issues related to the economic analysis of genomic diagnostic technologies in the UK National Health Service: an exploration of methods
90. Using orthopaedic health care resources efficiently: A cost analysis of day surgery for unicompartmental knee replacement.
91. Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial.
92. Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and Canada.
93. Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use.
94. Paving the path for implementation of clinical genomic sequencing globally: Are we ready?
95. Population screening requires robust evidence-genomics is no exception.
96. Adalimumab vs placebo as add-on to Standard Therapy for autoimmune Uveitis: Tolerability, Effectiveness and cost-effectiveness-a protocol for a randomised controlled trial (ASTUTE trial).
97. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia.
98. Cost-effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries.
99. HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead.
100. Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.